Ticker Scorecard - ZVRA Basics Company: Zevra Therapeutics, Inc. IPO Date: April 13, 2015 Sector: Healthcare Industry: Biotech Market Cap: $409.93M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.54% Avg Daily Range (30 D): $0.16 | 1.97% Avg Daily Range (90 D): $0.17 | 2.06% Institutional Daily Volume Avg Daily Volume: .35M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .43M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 51 Avg Inst. Trade: $1.7M Avg Inst. Trade (30 D): $1.55M Avg Inst. Trade (90 D): $1.67M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.67M Avg Closing Trade (30 D): $.66M Avg Closing Trade (90 D): $2.8M Avg Closing Volume: 557.43K     News Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A Nov 21, 2024 @ 9:51 PM Zevra Therapeutics Announces U.S. Commercial Avail... Source: N/A Nov 11, 2024 @ 9:36 PM Zevra Therapeutics to Present Data Demonstrating R... Source: Zevra Therapeutics, Inc. Aug 2, 2024 @ 9:50 PM FDA Advisory Committee Votes Favorably that the Da... Source: Zevra Therapeutics, Inc. Jun 25, 2024 @ 11:30 AM Zevra Therapeutics Expands Executive Leadership Te... Source: Zevra Therapeutics Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.69 $-.48 $-.4 Diluted EPS Revenue $ 3.7M $ 4.45M $ 3.43M Gross Profit $ $ $ Net Income / Loss $ -33.23M $ -19.93M $ -16.62M Operating Income / Loss $ -27.31M $ -23.8M $ -20.49M Cost of Revenue $ $ $ Net Cash Flow $ 15.27M $ -3.91M $ -.16M PE Ratio     Splits Dec 28, 2020:   16:1